WO2022191146A1 - Composition for use in voltage application cosmetic treatment, cosmetic sheet, cosmetic treatment device, and cosmetic method - Google Patents
Composition for use in voltage application cosmetic treatment, cosmetic sheet, cosmetic treatment device, and cosmetic method Download PDFInfo
- Publication number
- WO2022191146A1 WO2022191146A1 PCT/JP2022/009804 JP2022009804W WO2022191146A1 WO 2022191146 A1 WO2022191146 A1 WO 2022191146A1 JP 2022009804 W JP2022009804 W JP 2022009804W WO 2022191146 A1 WO2022191146 A1 WO 2022191146A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- cosmetic
- salt
- present
- voltage
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 98
- 239000002537 cosmetic Substances 0.000 title claims abstract description 81
- 238000011282 treatment Methods 0.000 title claims abstract description 52
- 238000000034 method Methods 0.000 title claims abstract description 17
- 229940079593 drug Drugs 0.000 claims description 30
- 239000003814 drug Substances 0.000 claims description 30
- 239000002562 thickening agent Substances 0.000 claims description 15
- 230000003796 beauty Effects 0.000 claims description 14
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- 230000002087 whitening effect Effects 0.000 claims description 7
- 230000002977 hyperthermial effect Effects 0.000 abstract 1
- 150000003839 salts Chemical group 0.000 description 24
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical class OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 22
- -1 ascorbic acid inorganic acid esters Chemical class 0.000 description 19
- 230000000694 effects Effects 0.000 description 16
- 229960005070 ascorbic acid Drugs 0.000 description 13
- 235000010323 ascorbic acid Nutrition 0.000 description 11
- 239000011668 ascorbic acid Substances 0.000 description 11
- 239000000463 material Substances 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 9
- 238000005259 measurement Methods 0.000 description 8
- 239000002585 base Substances 0.000 description 7
- 239000007844 bleaching agent Substances 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000002649 leather substitute Substances 0.000 description 4
- 239000000499 gel Substances 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- AUZQQIPZESHNMG-UHFFFAOYSA-N 3-methoxysalicylic acid Chemical compound COC1=CC=CC(C(O)=O)=C1O AUZQQIPZESHNMG-UHFFFAOYSA-N 0.000 description 2
- MRIXVKKOHPQOFK-UHFFFAOYSA-N 4-methoxysalicylic acid Chemical compound COC1=CC=C(C(O)=O)C(O)=C1 MRIXVKKOHPQOFK-UHFFFAOYSA-N 0.000 description 2
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- 150000000996 L-ascorbic acids Chemical class 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 238000005470 impregnation Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- FWFUWXVFYKCSQA-UHFFFAOYSA-M sodium;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C FWFUWXVFYKCSQA-UHFFFAOYSA-M 0.000 description 2
- AFQOCSDOKGNDNA-OBEHBXMUSA-N (2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one (Z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCC\C=C/CCCCCCCC(O)=O AFQOCSDOKGNDNA-OBEHBXMUSA-N 0.000 description 1
- VBURMNYQYXSQEL-VFAVKCLXSA-N (2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one (Z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O VBURMNYQYXSQEL-VFAVKCLXSA-N 0.000 description 1
- IRVNEGRHQKGRGD-WPXUHFOISA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;hexadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O IRVNEGRHQKGRGD-WPXUHFOISA-N 0.000 description 1
- PBTPTBMYJPCXRQ-MGMRMFRLSA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;hexadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O PBTPTBMYJPCXRQ-MGMRMFRLSA-N 0.000 description 1
- MHUOEHQATDLJFZ-WPXUHFOISA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;octadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O MHUOEHQATDLJFZ-WPXUHFOISA-N 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- JUIYTAQAHOONSH-UHFFFAOYSA-N 2-hydroxy-4-propan-2-yloxybenzoic acid Chemical compound CC(C)OC1=CC=C(C(O)=O)C(O)=C1 JUIYTAQAHOONSH-UHFFFAOYSA-N 0.000 description 1
- IXKMJGZLCSWMTD-UHFFFAOYSA-N 2-hydroxy-4-propoxybenzoic acid Chemical compound CCCOC1=CC=C(C(O)=O)C(O)=C1 IXKMJGZLCSWMTD-UHFFFAOYSA-N 0.000 description 1
- VHCJSVNQEBEVMO-UHFFFAOYSA-N 2-hydroxy-5-propoxybenzoic acid Chemical class CCCOC1=CC=C(O)C(C(O)=O)=C1 VHCJSVNQEBEVMO-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- CIHKVMHPDDJIIP-UHFFFAOYSA-N 2-methylperoxybenzoic acid Chemical class COOC1=CC=CC=C1C(O)=O CIHKVMHPDDJIIP-UHFFFAOYSA-N 0.000 description 1
- 229940078578 2-o-ethyl ascorbic acid Drugs 0.000 description 1
- PKYUNJWBVAXPMG-UHFFFAOYSA-N 3-ethoxy-2-hydroxybenzoic acid Chemical compound CCOC1=CC=CC(C(O)=O)=C1O PKYUNJWBVAXPMG-UHFFFAOYSA-N 0.000 description 1
- WHNPOQXWAMXPTA-UHFFFAOYSA-N 3-methylbut-2-enamide Chemical compound CC(C)=CC(N)=O WHNPOQXWAMXPTA-UHFFFAOYSA-N 0.000 description 1
- GXRFOOHMMLYYNW-UJURSFKZSA-N 3-o-Ethyl-L-ascorbic acid Chemical compound CCOC1=C(O)[C@@H]([C@@H](O)CO)OC1=O GXRFOOHMMLYYNW-UJURSFKZSA-N 0.000 description 1
- RNGFVIMNTYOBTK-UHFFFAOYSA-N 4-butoxy-2-hydroxybenzoic acid Chemical compound CCCCOC1=CC=C(C(O)=O)C(O)=C1 RNGFVIMNTYOBTK-UHFFFAOYSA-N 0.000 description 1
- DVZPQHRWOUXUPU-UHFFFAOYSA-N 4-ethoxy-2-hydroxybenzoic acid Chemical compound CCOC1=CC=C(C(O)=O)C(O)=C1 DVZPQHRWOUXUPU-UHFFFAOYSA-N 0.000 description 1
- ZZKFPIOJAOEMQL-UHFFFAOYSA-N 5-ethoxy-2-hydroxybenzoic acid Chemical class CCOC1=CC=C(O)C(C(O)=O)=C1 ZZKFPIOJAOEMQL-UHFFFAOYSA-N 0.000 description 1
- IZZIWIAOVZOBLF-UHFFFAOYSA-N 5-methyloxysalicylic acid Natural products COC1=CC=C(O)C(C(O)=O)=C1 IZZIWIAOVZOBLF-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- LITUBCVUXPBCGA-WMZHIEFXSA-N Ascorbyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O LITUBCVUXPBCGA-WMZHIEFXSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- XDBMXUKHMOFBPJ-ZAFYKAAXSA-N L-ascorbic acid 2-sulfate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OS(O)(=O)=O)=C1O XDBMXUKHMOFBPJ-ZAFYKAAXSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- YQINWFJNFJEWHH-UCLHFMLVSA-N OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O YQINWFJNFJEWHH-UCLHFMLVSA-N 0.000 description 1
- NGUBAXUPKACQCL-UCLHFMLVSA-N OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O NGUBAXUPKACQCL-UCLHFMLVSA-N 0.000 description 1
- QDTPSCIFGGYXJD-IPKXSQMUSA-N OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O QDTPSCIFGGYXJD-IPKXSQMUSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000037393 skin firmness Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 150000003673 urethanes Chemical class 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
Definitions
- the present invention relates to a composition for voltage-applied cosmetic treatment, a cosmetic sheet, a cosmetic treatment apparatus, and a cosmetic method.
- a voltage-applied beauty treatment device such as a high-frequency (RF) beauty device, that uses a high frequency band to give a thermal effect and increase skin firmness and elasticity.
- RF high-frequency
- Such a voltage-applied cosmetic treatment apparatus can warm the inside of the skin using a high frequency of, for example, about 1 MHz, promote the production of collagen and elastin, and improve wrinkles, firmness, and sagging.
- Patent Document 1 At least a high frequency generator that generates a high frequency of 14 MHz to 28 MHz and a conductor that is connected to the high frequency generator and directly contacts the face or skin surface where wrinkles are to be eliminated and emits a high frequency.
- a wrinkle removing device using high frequency characterized in that it comprises:
- Such voltage application cosmetic treatment devices generally require a special gel for application to the skin.
- An object of the present invention is to improve the above circumstances, and an object of the present invention is to provide a composition that can more efficiently perform a thermal effect on the skin using a voltage-applied cosmetic treatment apparatus. be.
- the present invention also provides a cosmetic sheet impregnated with the composition of the present invention, and a cosmetic treatment apparatus that applies a voltage to the skin via the composition or cosmetic sheet of the present invention.
- the present invention can further provide a cosmetic method using a voltage application cosmetic treatment device via the composition or cosmetic sheet of the present invention.
- cosmetic or “cosmetic method” means a method of beautifying the condition of the skin by beautifying it, and is different from a method of surgery, treatment or diagnosis of humans.
- ⁇ Aspect 1> A voltage-applied cosmetic treatment composition having an electrical conductivity of 0.5 S/m or more at 25°C.
- ⁇ Aspect 2> A composition according to aspect 1, comprising a drug in salt form.
- ⁇ Aspect 5> The ratio of the viscosity of the composition containing a thickener and containing the salt-form drug to the viscosity of the composition not containing the salt-form drug (when the salt-form drug is contained).
- the viscosity of the composition of / the viscosity of the composition when not containing the salt-type drug) is 50% or more, A composition according to any one of aspects 2-4.
- ⁇ Aspect 6> A cosmetic sheet impregnated with the composition according to any one of aspects 1 to 5.
- FIG. 1 shows the thermal effect of the compositions of Examples 1 and 3 and Comparative Examples 1 and 2.
- FIG. 1 shows the thermal effect of the compositions of Examples 1 and 3 and Comparative Examples 1 and 2.
- the voltage-applied cosmetic treatment composition of the present invention (hereinafter also simply referred to as “the composition of the present invention") comprises At 25° C., the electrical conductivity is 0.5 S/m or more.
- a voltage-applied cosmetic treatment device such as an RF beauty device generally requires a voltage-applied cosmetic treatment device composition (for example, a conventional exclusive gel composition) for application to the skin.
- a voltage-applied cosmetic treatment device composition for example, a conventional exclusive gel composition
- the present inventor has conducted extensive research and found that there is a correlation between the electrical conductivity of such a composition for a voltage-applied cosmetic treatment device and the thermal effect on the skin. It has been found that the higher the electrical conductivity of the applied cosmetic treatment device composition, the greater the thermal effect on the skin.
- composition of the present invention can exhibit the effects of the present invention by having a conductivity of 0.5 S/m or more at 25°C.
- the electrical conductivity of the composition of the present invention may be 0.5 S/m or more at 25° C., more specifically 0.5 S/m or more, 0.6 S/m or more, 0.7 S/m or more. 0.8 S/m or more, 0.9 S/m or more, 1.0 S/m or more, 1.1 S/m or more, 1.2 S/m or more, 1.3 S/m or more, 1.4 S/m or more , 1.5 S/m or more, 1.6 S/m or more, 1.7 S/m or more, 1.8 S/m or more, 1.9 S/m or more, 2.0 S/m or more, 2.1 S/m or more, 2.2 S/m or more, 2.3 S/m or more, 2.4 S/m or more, 2.5 S/m or more, 2.6 S/m or more, 2.7 S/m or more, or 2.8 S/m or more There may be.
- the upper limit of the conductivity of the composition of the present invention is not particularly limited, and varies depending on the type of component contained in the composition, the content of the component, etc. For example, 20 S / m or less, 10 S / m or less, 5.0 S/m or less, or 3.0 S/m or less.
- the conductivity may be measured at 25°C using, for example, a portable electrical conductivity meter ES-71 manufactured by HORIBA, Ltd.
- the electrical conductivity of the composition of the present invention can be adjusted by the type of component contained in the composition, the content of the component, or the like.
- the electrical conductivity can be adjusted by blending a salt-type drug, which will be described later, into the composition of the present invention.
- the viscosity of the composition of the present invention is not particularly limited, and may be, for example, 100 to 100,000 mPa ⁇ s at 25°C.
- the viscosity is preferably set high, for example, 1000 mPas or more, from the viewpoint of preventing dripping of the composition, preventing air bubbles, or reducing resistance when applied to the skin.
- the viscosity is preferably set low, for example, from the viewpoint of impregnation of the composition into a cosmetic sheet or the like, and may be, for example, 10000 mPa ⁇ s or less.
- the viscosity can be appropriately adjusted by adding a thickening agent or the like, which will be described later. Further, the viscosity can be measured at 25° C. using, for example, a TVB-10H type thermometer manufactured by Toki Sangyo Co., Ltd. under the measurement conditions used in the examples.
- compositions of the invention may contain one or more salt form agents.
- a salt-type drug means a drug that forms a salt form such as a sodium salt or a calcium salt and ionizes when dissolved in a solvent. The conductivity of the material can be adjusted.
- the salt-type drug according to the present invention may contain, for example, a salt-type whitening agent having a whitening function, an inorganic salt such as sodium chloride or calcium chloride, or sodium citrate, which can also serve as a pH adjuster.
- salt-type whitening agents are particularly preferably included from the viewpoint of efficiently achieving a whitening effect.
- an inorganic salt such as sodium chloride is particularly preferably included from the viewpoint of efficiently contributing to the improvement of electrical conductivity even in a small amount.
- a salt-type whitening agent means a whitening agent that is itself salt-type or neutralized with an alkaline agent to form a salt.
- salt-type whitening agents include, but are not limited to, salts of ascorbic acid-based whitening agents, salts of alkoxysalicylic acid-based whitening agents, and pyrimidylpyrazole compounds.
- Salts of ascorbic acid-based whitening agents include salts of ascorbic acid-based compounds composed of ascorbic acid and its derivatives.
- Specific examples of ascorbic acid include L-ascorbic acid.
- Examples of ascorbic acid derivatives include ascorbic acid inorganic acid esters such as L-ascorbic acid monophosphate, L-ascorbic acid-2-sulfate, and dl- ⁇ -tocopherol 2-L-ascorbic acid phosphate diester.
- ascorbic acid monoalkyl esters such as L-ascorbic acid monostearate, L-ascorbic acid monopalmitate, and L-ascorbic acid monooleate; L-ascorbic acid distearate, L-ascorbic acid dipalmitate, L-ascorbic acid dioleate, etc.
- Ascorbic acid diesters L-ascorbic acid tristearate, L-ascorbic acid tripalmitate, L-ascorbic acid trioleate and other ascorbic acid triesters; 2-O- ⁇ -D-glucopyranosyl-L-ascorbic acid and the like glycosides of ascorbic acid; ethyl vitamin C such as 2-O-ethyl ascorbic acid; Among these, ascorbic acid-2-glucoside is preferred.
- Salts of these ascorbic acid and ascorbic acid derivatives include alkali metal salts (Na salts, K salts, etc.), alkaline earth metal salts (Ca salts, Mg salts, etc.), ammonium salts, alkanolamine salts, amino acid salts, etc. include, but are not limited to.
- Salts of alkoxysalicylic acid whitening agents include, for example, 3-methoxysalicylic acid, 3-ethoxysalicylic acid, 4-methoxysalicylic acid, 4-ethoxysalicylic acid, 4-propoxysalicylic acid, 4-isopropoxysalicylic acid, 4-butoxysalicylic acid, 5- Examples include, but are not limited to, salts of methoxysalicylic acid, 5-ethoxysalicylic acid, or 5-propoxysalicylic acid.
- salts thereof include alkali metal salts (Na salts, K salts, etc.), alkaline earth metal salts (Ca salts, Mg salts, etc.), ammonium salts, alkanolamine salts, amino acid salts and the like. is not limited to
- the total content thereof is not particularly limited, and may be, for example, 0.2% by mass or more, 0.3% by mass or more, or 0.3% by mass or more, based on the total amount of the composition. 4% by mass or more, 0.5% by mass or more, 0.6% by mass or more, 0.7% by mass or more, 0.8% by mass or more, 0.9% by mass or more, 1.0% by mass or more, 1.5 % by mass or more, 2.0% by mass or more, 2.5% by mass or more, or 3.0% by mass or more, and 10% by mass or less, 5.0% by mass or less, 4.0% by mass or less, Alternatively, it may be 3.0% by mass or less.
- the composition of the invention may contain a thickening agent.
- a thickening agent for example, the salt-type drug according to the present invention
- the viscosity may decrease or air bubbles may be generated when the salt content is high. be. Therefore, in the present invention, salt-tolerant thickeners are preferable as the thickener from the viewpoint of preventing the composition from dripping, preventing air bubbles, or reducing resistance when applied to the skin.
- the composition of the present invention contains a thickener and the viscosity of the composition when it contains the above-mentioned salt-type drug, and the viscosity of the composition when it does not contain the above-mentioned salt-type drug.
- the viscosity ratio (viscosity of the composition containing the salt-type drug/viscosity of the composition not containing the salt-type drug) is preferably 50% or more. In addition, this ratio (viscosity of the composition containing the salt-type drug/viscosity of the composition not containing the salt-type drug) is 50% or more, 55% or more, 60% or more, 65% or more, 70% or more.
- a thickener having a ratio of 50% or more is treated as a "salt-tolerant thickener" and is also referred to as a "salt-tolerant thickener".
- salt-tolerant thickeners include (dimethylacrylamide/sodium acryloyldimethyltaurate) crosspolymer, succinoglycan, xanthan gum, cellulose, acrylamide-based copolymer, sodium acryloyldimethyltaurate/hydroxyethyl acrylate.
- examples include, but are not limited to, copolymers, agar, or hydrophobic polyether urethanes.
- the content of the thickener when it is included is not particularly limited, and is, for example, 0.01% by mass or more, 0.05% by mass or more, 1.0% or more, relative to the total amount of the composition. % by mass or more, 2.0% by mass or more, or 3.0% by mass or more, and may be 5.0% by mass or less.
- the composition of the present invention can be prepared by adding, for example, the aforementioned salt-type drug and/or thickener to an aqueous solvent such as ion-exchanged water and mixing.
- an aqueous solvent such as ion-exchanged water and mixing.
- the effects of the present invention are not impaired, for example, chelating agents, oils, surfactants, water-soluble alcohols, higher alcohols, powders, moisturizing agents, water-soluble polymer coating agents, ultraviolet absorbers, organic amines, polymers Emulsions, silicone elastomers, pH adjusters, skin nutrients, vitamins, antioxidants, antioxidant aids, extracts, preservatives, anti-inflammatory agents, activators, blood circulation promoters, antiseborrheic agents, dyes, pigments, Alternatively, one or more other components such as perfume may be added.
- the present invention also provides a cosmetic sheet.
- the cosmetic sheet is made by impregnating a base material with the desired liquid composition, and can be applied to the skin, and is particularly placed between the skin and the cosmetic treatment apparatus described below. point to
- the cosmetic sheet of the present invention is impregnated with the composition of the present invention described above.
- the amount of the composition of the present invention impregnated into the base material of the sheet varies depending on the material of the base material of the sheet. More specifically, the composition of the present invention may be impregnated in an amount of 1 to 30 times, or 5 to 20 times the mass of the base material of the sheet.
- non-woven fabric or paper may be used as the base material of the cosmetic sheet.
- material of the fibers that make up the non-woven fabric cotton, rayon, pulp, hemp, acrylic, nylon, silk, polyamide, polyester, polyurethane, polypropylene, etc., and mixtures thereof are used. It is preferable because it has high impregnation retention and good texture.
- the shape of the cosmetic sheet is not particularly limited, and may be appropriately set according to the site of use of the skin. are not limited to these.
- the cosmetic sheet may be provided with protrusions or recesses in the central part or the peripheral part for the purpose of alignment and usability improvement, and the thickness and composition of the cosmetic sheet may be changed depending on the use site.
- the method for impregnating the base material of the sheet with the composition of the present invention is not particularly limited, and examples thereof include a known dropping method, spraying method, pressurizing method, or dipping method.
- the base material of the sheet can be used as it is or as a folded sheet or a plurality of sheets, and can be impregnated with the composition of the present invention.
- the present invention also provides a cosmetic treatment device.
- the cosmetic treatment apparatus of the present invention is a cosmetic treatment apparatus that performs voltage application cosmetic treatment on the skin via the composition of the present invention described above or the cosmetic sheet of the present invention described above, including a voltage application unit and a control unit,
- the voltage application unit has at least two electrodes on the same plane, and the control unit controls the frequency of the AC voltage or DC pulse voltage between the at least two electrodes of the voltage application unit to 500 kHz to 50 MHz. It is a device.
- passing the composition of the present invention or the cosmetic sheet of the present invention means that the composition of the present invention or the cosmetic sheet of the present invention is placed between the cosmetic treatment device and the skin when the skin is treated with the cosmetic treatment device. This is a mode in which the cosmetic sheet is brought into contact with both.
- the composition of the present invention may be applied to the cosmetic treatment device, may be applied to the skin, or may be applied to both the cosmetic treatment device and the skin. It may be coated.
- the cosmetic sheet of the present invention it is preferable to cover the skin with the cosmetic sheet of the present invention first, and then apply the cosmetic treatment device, depending on the size of the sheet, from the viewpoint of convenience of operation. .
- the voltage application section has at least two electrodes on the same plane, and the two electrodes can apply a high-frequency voltage to the skin.
- the high-frequency voltage may be, for example, voltage with a frequency of 500 kHz to 50 MHz.
- control section can control the frequency of the AC voltage or DC pulse voltage between at least two electrodes of the voltage application section to, for example, 500 kHz to 50 MHz.
- the beauty treatment device may further include, for example, a measurement unit that measures the resistance value between the two electrodes.
- the control section can control the frequency of the AC voltage or the DC pulse voltage to, for example, 500 kHz to 50 MHz according to the resistance value obtained from the measurement section.
- a commercially available beauty treatment device that performs voltage application beauty treatment on the skin, such as an RF facial equipment, may be used.
- the thermal effect on the skin can be more efficiently performed through the composition of the present invention or the cosmetic sheet impregnated with the composition of the present invention.
- the present invention also provides a cosmetic method.
- the cosmetic method of the present invention is a method using a voltage-applied cosmetic treatment apparatus via the composition of the present invention or the cosmetic sheet of the present invention.
- the voltage application cosmetic treatment apparatus the above-described beauty treatment apparatus of the present invention may be used, or a commercially available beauty treatment apparatus for applying voltage application cosmetic treatment to the skin, for example, an RF facial device may be used.
- the thermal effect on the skin can be performed more efficiently through the composition of the present invention or the cosmetic sheet impregnated with the composition of the present invention.
- Viscosity was measured for some of the Example and Comparative compositions and the results are shown in Tables 1-5. Then, for those compositions, the ratio of the viscosity of the composition containing the salt-type drug to the viscosity of the composition not containing the salt-type drug (viscosity of the composition containing the salt-type drug /viscosity of the composition without salt-type drug) was determined and shown in Tables 1-5.
- the viscosity was measured using a TVB-10H degree meter manufactured by Toki Sangyo Co., Ltd.
- the measurement conditions were 25° C., a rotor NoTH7, a rotation speed of 10 rpm, and a viscosity value after 60 seconds of rotation.
- a 30 mm ⁇ 30 mm piece of artificial leather (Suprale, manufactured by Idemitsu Techno Fine Co., Ltd.) is placed on a cheek skin model manufactured by Beaulux Co., Ltd., and 20 mg/cm 2 of each composition sample is placed on the artificial leather piece. applied.
- an electrode that outputs a voltage with a frequency of 1 MHz was applied to the piece of artificial leather coated with the composition sample, and the temperature was measured.
- a non-coated sample was used as a blank.
- the temperature measurement was performed by attaching a thermocouple between the cheek model and the piece of artificial leather and recording it with a memory high logger LR8431 manufactured by Hioki Electric Co., Ltd., starting measurement 10 seconds before applying the electrode, and displaying the temperature. Measurements were taken until the temperature exceeded 50° C. or 2 minutes (120 seconds) elapsed.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Provided are: a composition which is for use in voltage application cosmetic treatment, and by which it is possible to more efficiently obtain a hyperthermic effect on the skin using a voltage application cosmetic treatment device; a cosmetic sheet; a cosmetic treatment device; and a cosmetic method. The composition for use in voltage application cosmetic treatment has an electrical conductivity of 0.5 S/m or higher at 25°C.
Description
本発明は、電圧印加美容処理用組成物、美容シート、美容処理装置、及び美容方法に関する。
The present invention relates to a composition for voltage-applied cosmetic treatment, a cosmetic sheet, a cosmetic treatment apparatus, and a cosmetic method.
近年、高周波（ＲＦ）美容器等の、高い周波数帯を利用して、温熱効果を与え、肌のハリ、弾力を高めるための電圧印加美容処理装置が知られている。このような電圧印加美容処理装置では、例えば１ＭＨｚ程度の高周波を用いて肌の内部を温め、コラーゲン・エラスチンの生成を促し、シワ・ハリ・たるみの改善を図ることができる。
In recent years, there has been known a voltage-applied beauty treatment device, such as a high-frequency (RF) beauty device, that uses a high frequency band to give a thermal effect and increase skin firmness and elasticity. Such a voltage-applied cosmetic treatment apparatus can warm the inside of the skin using a high frequency of, for example, about 1 MHz, promote the production of collagen and elastin, and improve wrinkles, firmness, and sagging.
例えば、特許文献１では、１４ＭＨｚ～２８ＭＨｚの高周波を発生する高周波発生器と、該高周波発生器に接続され皺を解消する箇所の顔や皮膚表面に直接接触して高周波を発する導子とを少なくとも備えた構成からなることを特徴とする、高周波を利用した皺解消装置が開示されている。
For example, in Patent Document 1, at least a high frequency generator that generates a high frequency of 14 MHz to 28 MHz and a conductor that is connected to the high frequency generator and directly contacts the face or skin surface where wrinkles are to be eliminated and emits a high frequency. Disclosed is a wrinkle removing device using high frequency, characterized in that it comprises:
このような電圧印加美容処理装置は、一般的に、皮膚に適用するための専用ジェルが必要である。
Such voltage application cosmetic treatment devices generally require a special gel for application to the skin.
しかしながら、従来の専用ジェル組成物は、その成分によっては皮膚への温熱効果が十分とは言えない場合がある。
However, conventional dedicated gel compositions may not have a sufficient thermal effect on the skin depending on the ingredients.
本発明は、上記の事情を改善しようとするものであり、その目的は、電圧印加美容処理装置を用いて、皮膚への温熱効果をより効率的に行うことができる組成物を提供することである。
An object of the present invention is to improve the above circumstances, and an object of the present invention is to provide a composition that can more efficiently perform a thermal effect on the skin using a voltage-applied cosmetic treatment apparatus. be.
本発明はまた、本発明の組成物が含浸されている美容シート、本発明の組成物、又は美容シートを介して、皮膚に電圧印加美容処理を行う美容処理装置を提供することである。
The present invention also provides a cosmetic sheet impregnated with the composition of the present invention, and a cosmetic treatment apparatus that applies a voltage to the skin via the composition or cosmetic sheet of the present invention.
本発明は更に、本発明の組成物又は美容シートを介して、電圧印加美容処理装置を用いる美容方法を提供することができる。
The present invention can further provide a cosmetic method using a voltage application cosmetic treatment device via the composition or cosmetic sheet of the present invention.
なお、本発明において、「美容」又は「美容方法」とは、皮膚の状態を美しく整えて美化する方法を意味し、人間を手術、治療又は診断する方法とは相違する。
In the present invention, "cosmetic" or "cosmetic method" means a method of beautifying the condition of the skin by beautifying it, and is different from a method of surgery, treatment or diagnosis of humans.
上記の目的を達成する本発明は、以下のとおりである。
The present invention that achieves the above objects is as follows.
〈態様１〉
２５℃において、導電率が０．５Ｓ／ｍ以上である、電圧印加美容処理用組成物。
〈態様２〉
塩型薬剤を含有している、態様１に記載の組成物。
〈態様３〉
前記塩型薬剤が、塩型美白剤を含む、態様２に記載の組成物。
〈態様４〉
前記塩型薬剤の含有量が、０．２質量％以上である、態様２又は３に記載の組成物。
〈態様５〉
増粘剤を含有し、かつ
前記塩型薬剤を含有する場合の前記組成物の粘度と、前記塩型薬剤を含有しない場合の前記組成物の粘度との比（前記塩型薬剤を含有する場合の前記組成物の粘度／前記塩型薬剤を含有しない場合の前記組成物の粘度）が、５０％以上である、
態様２～４のいずれか一項に記載の組成物。
〈態様６〉
態様１～５のいずれか一項に記載の組成物が含浸されている、美容シート。
〈態様７〉
態様１～５のいずれか一項に記載の組成物、又は態様６に記載の美容シートを介して、皮膚に電圧印加美容処理を行う美容処理装置であって、
電圧印加部及び制御部を含み、
前記電圧印加部が、同一の平面上に少なくとも２つの電極を有し、かつ
前記制御部が、前記電圧印加部の少なくとも２つの前記電極間の交流電圧又は直流パルス電圧の周波数を５００ｋＨｚ～５０ＭＨｚに制御する、
装置。
〈態様８〉
態様１～５のいずれか一項に記載の組成物、又は態様６に記載の美容シートを介して、電圧印加美容処理装置を用いる、美容方法。 <Aspect 1>
A voltage-applied cosmetic treatment composition having an electrical conductivity of 0.5 S/m or more at 25°C.
<Aspect 2>
A composition according toaspect 1, comprising a drug in salt form.
<Aspect 3>
3. The composition of aspect 2, wherein the salt-type agent comprises a salt-type whitening agent.
<Aspect 4>
The composition according to aspect 2 or 3, wherein the content of the salt-type drug is 0.2% by mass or more.
<Aspect 5>
The ratio of the viscosity of the composition containing a thickener and containing the salt-form drug to the viscosity of the composition not containing the salt-form drug (when the salt-form drug is contained The viscosity of the composition of / the viscosity of the composition when not containing the salt-type drug) is 50% or more,
A composition according to any one of aspects 2-4.
<Aspect 6>
A cosmetic sheet impregnated with the composition according to any one ofaspects 1 to 5.
<Aspect 7>
A cosmetic treatment apparatus for performing voltage application cosmetic treatment on the skin via the composition according to any one ofaspects 1 to 5 or the cosmetic sheet according to aspect 6,
including a voltage application unit and a control unit,
The voltage application unit has at least two electrodes on the same plane, and the control unit sets the frequency of the AC voltage or DC pulse voltage between the at least two electrodes of the voltage application unit to 500 kHz to 50 MHz. Control,
Device.
<Aspect 8>
A cosmetic method using a voltage applying cosmetic treatment apparatus via the composition according to any one ofaspects 1 to 5 or the cosmetic sheet according to aspect 6.
２５℃において、導電率が０．５Ｓ／ｍ以上である、電圧印加美容処理用組成物。
〈態様２〉
塩型薬剤を含有している、態様１に記載の組成物。
〈態様３〉
前記塩型薬剤が、塩型美白剤を含む、態様２に記載の組成物。
〈態様４〉
前記塩型薬剤の含有量が、０．２質量％以上である、態様２又は３に記載の組成物。
〈態様５〉
増粘剤を含有し、かつ
前記塩型薬剤を含有する場合の前記組成物の粘度と、前記塩型薬剤を含有しない場合の前記組成物の粘度との比（前記塩型薬剤を含有する場合の前記組成物の粘度／前記塩型薬剤を含有しない場合の前記組成物の粘度）が、５０％以上である、
態様２～４のいずれか一項に記載の組成物。
〈態様６〉
態様１～５のいずれか一項に記載の組成物が含浸されている、美容シート。
〈態様７〉
態様１～５のいずれか一項に記載の組成物、又は態様６に記載の美容シートを介して、皮膚に電圧印加美容処理を行う美容処理装置であって、
電圧印加部及び制御部を含み、
前記電圧印加部が、同一の平面上に少なくとも２つの電極を有し、かつ
前記制御部が、前記電圧印加部の少なくとも２つの前記電極間の交流電圧又は直流パルス電圧の周波数を５００ｋＨｚ～５０ＭＨｚに制御する、
装置。
〈態様８〉
態様１～５のいずれか一項に記載の組成物、又は態様６に記載の美容シートを介して、電圧印加美容処理装置を用いる、美容方法。 <
A voltage-applied cosmetic treatment composition having an electrical conductivity of 0.5 S/m or more at 25°C.
<Aspect 2>
A composition according to
<Aspect 3>
3. The composition of aspect 2, wherein the salt-type agent comprises a salt-type whitening agent.
<Aspect 4>
The composition according to aspect 2 or 3, wherein the content of the salt-type drug is 0.2% by mass or more.
<Aspect 5>
The ratio of the viscosity of the composition containing a thickener and containing the salt-form drug to the viscosity of the composition not containing the salt-form drug (when the salt-form drug is contained The viscosity of the composition of / the viscosity of the composition when not containing the salt-type drug) is 50% or more,
A composition according to any one of aspects 2-4.
<Aspect 6>
A cosmetic sheet impregnated with the composition according to any one of
<Aspect 7>
A cosmetic treatment apparatus for performing voltage application cosmetic treatment on the skin via the composition according to any one of
including a voltage application unit and a control unit,
The voltage application unit has at least two electrodes on the same plane, and the control unit sets the frequency of the AC voltage or DC pulse voltage between the at least two electrodes of the voltage application unit to 500 kHz to 50 MHz. Control,
Device.
<Aspect 8>
A cosmetic method using a voltage applying cosmetic treatment apparatus via the composition according to any one of
本発明によれば、電圧印加美容処理装置を用いて、皮膚への温熱効果をより効率的に得ることができる。
According to the present invention, it is possible to more efficiently obtain a thermal effect on the skin using a voltage application cosmetic treatment apparatus.
以下、本発明の実施の形態について詳述する。なお、本発明は、以下の実施の形態に限定されるものではなく、発明の本旨の範囲内で種々変形して実施できる。
The embodiment of the present invention will be described in detail below. It should be noted that the present invention is not limited to the following embodiments, and can be carried out with various modifications within the scope of the gist of the invention.
《電圧印加美容処理用組成物》
本発明の電圧印加美容処理用組成物（以下、単に「本発明の組成物」とも称する）は、
２５℃において、導電率が０．５Ｓ／ｍ以上である。 <<Composition for Voltage Application Cosmetic Treatment>>
The voltage-applied cosmetic treatment composition of the present invention (hereinafter also simply referred to as "the composition of the present invention") comprises
At 25° C., the electrical conductivity is 0.5 S/m or more.
本発明の電圧印加美容処理用組成物（以下、単に「本発明の組成物」とも称する）は、
２５℃において、導電率が０．５Ｓ／ｍ以上である。 <<Composition for Voltage Application Cosmetic Treatment>>
The voltage-applied cosmetic treatment composition of the present invention (hereinafter also simply referred to as "the composition of the present invention") comprises
At 25° C., the electrical conductivity is 0.5 S/m or more.
上述したように、ＲＦ美容器等の電圧印加美容処理装置は、一般的に、皮膚に適用するための電圧印加美容処理装置用組成物（例えば、従来の専用ジェル組成物）が必要である。
As described above, a voltage-applied cosmetic treatment device such as an RF beauty device generally requires a voltage-applied cosmetic treatment device composition (for example, a conventional exclusive gel composition) for application to the skin.
これに関して、本発明者の鋭意研究によって、このような電圧印加美容処理装置用組成物の導電率と、皮膚への温熱効果との相関があることが見出され、より具体的には、電圧印加美容処理装置用組成物の導電率が高いほど、皮膚への温熱効果がより大きくなることが見出された。
In this regard, the present inventor has conducted extensive research and found that there is a correlation between the electrical conductivity of such a composition for a voltage-applied cosmetic treatment device and the thermal effect on the skin. It has been found that the higher the electrical conductivity of the applied cosmetic treatment device composition, the greater the thermal effect on the skin.
したがって、本発明の組成物は、２５℃において、導電率が０．５Ｓ／ｍ以上であることによって、本発明の効果を発揮させることができる。
Therefore, the composition of the present invention can exhibit the effects of the present invention by having a conductivity of 0.5 S/m or more at 25°C.
（導電率）
本発明の組成物の導電率は、２５℃において、０．５Ｓ／ｍ以上であればよく、より具体的には、０．５Ｓ／ｍ以上、０．６Ｓ／ｍ以上、０．７Ｓ／ｍ以上、０．８Ｓ／ｍ以上、０．９Ｓ／ｍ以上、１．０Ｓ／ｍ以上、１．１Ｓ／ｍ以上、１．２Ｓ／ｍ以上、１．３Ｓ／ｍ以上、１．４Ｓ／ｍ以上、１．５Ｓ／ｍ以上、１．６Ｓ／ｍ以上、１．７Ｓ／ｍ以上、１．８Ｓ／ｍ以上、１．９Ｓ／ｍ以上、２．０Ｓ／ｍ以上、２．１Ｓ／ｍ以上、２．２Ｓ／ｍ以上、２．３Ｓ／ｍ以上、２．４Ｓ／ｍ以上、２．５Ｓ／ｍ以上、２．６Ｓ／ｍ以上、２．７Ｓ／ｍ以上、又は２．８Ｓ／ｍ以上であってもよい。また、本発明の組成物の導電率の上限値は、特に限定されず、組成物に含まれる成分の種類、又は成分の含有量等によって変動するものであり、例えば２０Ｓ／ｍ以下、１０Ｓ／ｍ以下、５．０Ｓ／ｍ以下、又は３．０Ｓ／ｍ以下であってもよい。 (conductivity)
The electrical conductivity of the composition of the present invention may be 0.5 S/m or more at 25° C., more specifically 0.5 S/m or more, 0.6 S/m or more, 0.7 S/m or more. 0.8 S/m or more, 0.9 S/m or more, 1.0 S/m or more, 1.1 S/m or more, 1.2 S/m or more, 1.3 S/m or more, 1.4 S/m or more , 1.5 S/m or more, 1.6 S/m or more, 1.7 S/m or more, 1.8 S/m or more, 1.9 S/m or more, 2.0 S/m or more, 2.1 S/m or more, 2.2 S/m or more, 2.3 S/m or more, 2.4 S/m or more, 2.5 S/m or more, 2.6 S/m or more, 2.7 S/m or more, or 2.8 S/m or more There may be. Further, the upper limit of the conductivity of the composition of the present invention is not particularly limited, and varies depending on the type of component contained in the composition, the content of the component, etc. For example, 20 S / m or less, 10 S / m or less, 5.0 S/m or less, or 3.0 S/m or less.
本発明の組成物の導電率は、２５℃において、０．５Ｓ／ｍ以上であればよく、より具体的には、０．５Ｓ／ｍ以上、０．６Ｓ／ｍ以上、０．７Ｓ／ｍ以上、０．８Ｓ／ｍ以上、０．９Ｓ／ｍ以上、１．０Ｓ／ｍ以上、１．１Ｓ／ｍ以上、１．２Ｓ／ｍ以上、１．３Ｓ／ｍ以上、１．４Ｓ／ｍ以上、１．５Ｓ／ｍ以上、１．６Ｓ／ｍ以上、１．７Ｓ／ｍ以上、１．８Ｓ／ｍ以上、１．９Ｓ／ｍ以上、２．０Ｓ／ｍ以上、２．１Ｓ／ｍ以上、２．２Ｓ／ｍ以上、２．３Ｓ／ｍ以上、２．４Ｓ／ｍ以上、２．５Ｓ／ｍ以上、２．６Ｓ／ｍ以上、２．７Ｓ／ｍ以上、又は２．８Ｓ／ｍ以上であってもよい。また、本発明の組成物の導電率の上限値は、特に限定されず、組成物に含まれる成分の種類、又は成分の含有量等によって変動するものであり、例えば２０Ｓ／ｍ以下、１０Ｓ／ｍ以下、５．０Ｓ／ｍ以下、又は３．０Ｓ／ｍ以下であってもよい。 (conductivity)
The electrical conductivity of the composition of the present invention may be 0.5 S/m or more at 25° C., more specifically 0.5 S/m or more, 0.6 S/m or more, 0.7 S/m or more. 0.8 S/m or more, 0.9 S/m or more, 1.0 S/m or more, 1.1 S/m or more, 1.2 S/m or more, 1.3 S/m or more, 1.4 S/m or more , 1.5 S/m or more, 1.6 S/m or more, 1.7 S/m or more, 1.8 S/m or more, 1.9 S/m or more, 2.0 S/m or more, 2.1 S/m or more, 2.2 S/m or more, 2.3 S/m or more, 2.4 S/m or more, 2.5 S/m or more, 2.6 S/m or more, 2.7 S/m or more, or 2.8 S/m or more There may be. Further, the upper limit of the conductivity of the composition of the present invention is not particularly limited, and varies depending on the type of component contained in the composition, the content of the component, etc. For example, 20 S / m or less, 10 S / m or less, 5.0 S/m or less, or 3.0 S/m or less.
なお、導電率の測定は、２５℃において、例えば、株式会社堀場製作所社製のポータブル型電気伝導率計ＥＳ－７１を用いて行ってよい。
The conductivity may be measured at 25°C using, for example, a portable electrical conductivity meter ES-71 manufactured by HORIBA, Ltd.
また、本発明の組成物の導電率は、組成物に含まれる成分の種類、又は成分の含有量等によって調整することができる。一例としては、後述する塩型薬剤を本発明の組成物に配合することによって、導電率を調整することができる。
In addition, the electrical conductivity of the composition of the present invention can be adjusted by the type of component contained in the composition, the content of the component, or the like. As an example, the electrical conductivity can be adjusted by blending a salt-type drug, which will be described later, into the composition of the present invention.
（粘度）
本発明の組成物の粘度は、特に限定されず、例えば２５℃において、１００～１０００００ｍＰａ・ｓであってよい。粘度は、例えば組成物の垂れ防止、気泡防止、又は皮膚への適用の際の抵抗低減の観点からは、高く設定することが好ましく、例えば１０００ｍＰａｓ以上であってよい。また、粘度は、例えば組成物の美容シート等への含浸性の観点からは、低く設定することが好ましく、例えば１００００ｍＰａ・ｓ以下であってよい。なお、粘度は、後述する増粘剤等を配合することによって適宜調整できる。また、粘度は、２５℃において、例えば、東機産業株式会社製のＴＶＢ－１０Ｈ型度計を用いて、実施例で行った測定条件によって測定することができる。 (viscosity)
The viscosity of the composition of the present invention is not particularly limited, and may be, for example, 100 to 100,000 mPa·s at 25°C. The viscosity is preferably set high, for example, 1000 mPas or more, from the viewpoint of preventing dripping of the composition, preventing air bubbles, or reducing resistance when applied to the skin. Also, the viscosity is preferably set low, for example, from the viewpoint of impregnation of the composition into a cosmetic sheet or the like, and may be, for example, 10000 mPa·s or less. The viscosity can be appropriately adjusted by adding a thickening agent or the like, which will be described later. Further, the viscosity can be measured at 25° C. using, for example, a TVB-10H type thermometer manufactured by Toki Sangyo Co., Ltd. under the measurement conditions used in the examples.
本発明の組成物の粘度は、特に限定されず、例えば２５℃において、１００～１０００００ｍＰａ・ｓであってよい。粘度は、例えば組成物の垂れ防止、気泡防止、又は皮膚への適用の際の抵抗低減の観点からは、高く設定することが好ましく、例えば１０００ｍＰａｓ以上であってよい。また、粘度は、例えば組成物の美容シート等への含浸性の観点からは、低く設定することが好ましく、例えば１００００ｍＰａ・ｓ以下であってよい。なお、粘度は、後述する増粘剤等を配合することによって適宜調整できる。また、粘度は、２５℃において、例えば、東機産業株式会社製のＴＶＢ－１０Ｈ型度計を用いて、実施例で行った測定条件によって測定することができる。 (viscosity)
The viscosity of the composition of the present invention is not particularly limited, and may be, for example, 100 to 100,000 mPa·s at 25°C. The viscosity is preferably set high, for example, 1000 mPas or more, from the viewpoint of preventing dripping of the composition, preventing air bubbles, or reducing resistance when applied to the skin. Also, the viscosity is preferably set low, for example, from the viewpoint of impregnation of the composition into a cosmetic sheet or the like, and may be, for example, 10000 mPa·s or less. The viscosity can be appropriately adjusted by adding a thickening agent or the like, which will be described later. Further, the viscosity can be measured at 25° C. using, for example, a TVB-10H type thermometer manufactured by Toki Sangyo Co., Ltd. under the measurement conditions used in the examples.
〈塩型薬剤〉
本発明の組成物は、１種類以上の塩型薬剤を含有していてもよい。塩型薬剤とは、ナトリウム塩、カルシウム塩等の塩の形態を形成し、溶媒中に溶解した際に電離する薬剤を意味し、このような塩型薬剤を配合することによって、本発明の組成物の導電率を調整することができる。 <Salt-type drug>
Compositions of the invention may contain one or more salt form agents. A salt-type drug means a drug that forms a salt form such as a sodium salt or a calcium salt and ionizes when dissolved in a solvent. The conductivity of the material can be adjusted.
本発明の組成物は、１種類以上の塩型薬剤を含有していてもよい。塩型薬剤とは、ナトリウム塩、カルシウム塩等の塩の形態を形成し、溶媒中に溶解した際に電離する薬剤を意味し、このような塩型薬剤を配合することによって、本発明の組成物の導電率を調整することができる。 <Salt-type drug>
Compositions of the invention may contain one or more salt form agents. A salt-type drug means a drug that forms a salt form such as a sodium salt or a calcium salt and ionizes when dissolved in a solvent. The conductivity of the material can be adjusted.
本発明にかかる塩型薬剤は、例えば美白機能を有する塩型美白剤、塩化ナトリウム若しくは塩化カルシウム等の無機塩、又はｐＨ調整剤ともなりうるクエン酸ナトリウムを含んでよい。これらのうち、美白効果を効率的に果たせる観点からは、特に塩型美白剤を好ましく含まれる。また、分子量の小ささ故、少ない配合量でも導電率の向上に効率よく寄与できる観点からは特に塩化ナトリウムのような無機塩が好ましく含まれる。
The salt-type drug according to the present invention may contain, for example, a salt-type whitening agent having a whitening function, an inorganic salt such as sodium chloride or calcium chloride, or sodium citrate, which can also serve as a pH adjuster. Among these, salt-type whitening agents are particularly preferably included from the viewpoint of efficiently achieving a whitening effect. Moreover, because of its small molecular weight, an inorganic salt such as sodium chloride is particularly preferably included from the viewpoint of efficiently contributing to the improvement of electrical conductivity even in a small amount.
本発明において、塩型美白剤とは、それ自体が塩型であるか、あるいはアルカリ剤により中和されて塩を形成する美白剤を意味する。
In the present invention, a salt-type whitening agent means a whitening agent that is itself salt-type or neutralized with an alkaline agent to form a salt.
塩型美白剤としては、例えばアスコルビン酸系美白剤の塩、アルコキシサリチル酸系美白剤の塩、又はピリミジルピラゾール化合物等が挙げられるが、これらに限定されない。
Examples of salt-type whitening agents include, but are not limited to, salts of ascorbic acid-based whitening agents, salts of alkoxysalicylic acid-based whitening agents, and pyrimidylpyrazole compounds.
アスコルビン酸系美白剤の塩としては、アスコルビン酸及びその誘導体からなるアスコルビン酸系化合物の塩が挙げられる。具体例しては、アスコルビン酸としては、Ｌ－アスコルビン酸が挙げられる。また、アスコルビン酸誘導体としては、例えば、Ｌ－アスコルビン酸モノリン酸エステル、Ｌ－アスコルビン酸－２－硫酸エステル、ｄｌ－α－トコフェロール２－Ｌ－アスコルビン酸リン酸ジエステル等のアスコルビン酸無機酸エステル類；Ｌ－アスコルビン酸モノステアレート、Ｌ－アスコルビン酸モノパルミテート、Ｌ－アスコルビン酸モノオレエート等のアスコルビン酸モノアルキルエステル類；Ｌ－アスコルビン酸ジステアレート、Ｌ－アスコルビン酸ジパルミテート、Ｌ－アスコルビン酸ジオレエート等のアスコルビン酸ジエステル類；Ｌ－アスコルビン酸トリステアレート、Ｌ－アスコルビン酸トリパルミテート、Ｌ－アスコルビン酸トリオレエート等のアスコルビン酸トリエステル類；２－Ｏ－α－Ｄ－グルコピラノシル－Ｌ－アスコルビン酸等のアスコルビン酸グリコシド；２－Ｏ－エチルアスコルビン酸等のエチルビタミンＣ、等が挙げられる。これらのうち、好ましいものとしてはアスコルビン酸－２－グルコシドが挙げられる。また、これらアスコルビン酸及びアスコルビン酸誘導体の塩としては、アルカリ金属塩（Ｎａ塩、Ｋ塩等）、アルカリ土類金属塩（Ｃａ塩、Ｍｇ塩等）、アンモニウム塩、アルカノールアミン塩、アミノ酸塩などが挙げられるが、これらに限定されない。
Salts of ascorbic acid-based whitening agents include salts of ascorbic acid-based compounds composed of ascorbic acid and its derivatives. Specific examples of ascorbic acid include L-ascorbic acid. Examples of ascorbic acid derivatives include ascorbic acid inorganic acid esters such as L-ascorbic acid monophosphate, L-ascorbic acid-2-sulfate, and dl-α-tocopherol 2-L-ascorbic acid phosphate diester. ascorbic acid monoalkyl esters such as L-ascorbic acid monostearate, L-ascorbic acid monopalmitate, and L-ascorbic acid monooleate; L-ascorbic acid distearate, L-ascorbic acid dipalmitate, L-ascorbic acid dioleate, etc. Ascorbic acid diesters; L-ascorbic acid tristearate, L-ascorbic acid tripalmitate, L-ascorbic acid trioleate and other ascorbic acid triesters; 2-O-α-D-glucopyranosyl-L-ascorbic acid and the like glycosides of ascorbic acid; ethyl vitamin C such as 2-O-ethyl ascorbic acid; Among these, ascorbic acid-2-glucoside is preferred. Salts of these ascorbic acid and ascorbic acid derivatives include alkali metal salts (Na salts, K salts, etc.), alkaline earth metal salts (Ca salts, Mg salts, etc.), ammonium salts, alkanolamine salts, amino acid salts, etc. include, but are not limited to.
アルコキシサリチル酸系美白剤の塩としては、例えば、３－メトキシサリチル酸、３－エトキシサリチル酸、４－メトキシサリチル酸、４－エトキシサリチル酸、４－プロポキシサリチル酸、４－イソプロポキシサリチル酸、４－ブトキシサリチル酸、５－メトキシサリチル酸、５－エトキシサリチル酸、又は５－プロポシキサリチル酸の塩が挙げられるが、これらに限定されない。また、これらの塩としては、アルカリ金属塩（Ｎａ塩、Ｋ塩等）、アルカリ土類金属塩（Ｃａ塩、Ｍｇ塩等）、アンモニウム塩、アルカノールアミン塩、アミノ酸塩などが挙げられるが、これらに限定されない。
Salts of alkoxysalicylic acid whitening agents include, for example, 3-methoxysalicylic acid, 3-ethoxysalicylic acid, 4-methoxysalicylic acid, 4-ethoxysalicylic acid, 4-propoxysalicylic acid, 4-isopropoxysalicylic acid, 4-butoxysalicylic acid, 5- Examples include, but are not limited to, salts of methoxysalicylic acid, 5-ethoxysalicylic acid, or 5-propoxysalicylic acid. Examples of salts thereof include alkali metal salts (Na salts, K salts, etc.), alkaline earth metal salts (Ca salts, Mg salts, etc.), ammonium salts, alkanolamine salts, amino acid salts and the like. is not limited to
本発明の組成物において、塩型薬剤が含まれる場合のその合計含有量は、特に限定されず、組成物全量に対して、例えば０．２質量％以上、０．３質量％以上、０．４質量％以上、０．５質量％以上、０．６質量％以上、０．７質量％以上、０．８質量％以上、０．９質量％以上、１．０質量％以上、１．５質量％以上、２．０質量％以上、２．５質量％以上、又は３．０質量％以上であってよく、また１０質量％以下、５．０質量％以下、４．０質量％以下、又は３．０質量％以下であってよい。
When the composition of the present invention contains a salt-type drug, the total content thereof is not particularly limited, and may be, for example, 0.2% by mass or more, 0.3% by mass or more, or 0.3% by mass or more, based on the total amount of the composition. 4% by mass or more, 0.5% by mass or more, 0.6% by mass or more, 0.7% by mass or more, 0.8% by mass or more, 0.9% by mass or more, 1.0% by mass or more, 1.5 % by mass or more, 2.0% by mass or more, 2.5% by mass or more, or 3.0% by mass or more, and 10% by mass or less, 5.0% by mass or less, 4.0% by mass or less, Alternatively, it may be 3.0% by mass or less.
〈増粘剤〉
本発明の組成物は、増粘剤を含有してもよい。増粘剤は、通常、塩（例えば、本発明にかかる塩型薬剤等）と併用すると、塩の含有量が多い場合には粘度が低下してしまうことや、気泡が発生してしまうことがある。したがって、本発明において、例えば組成物の垂れ防止、気泡防止、又は皮膚への適用の際の抵抗低減の観点からは、増粘剤として、耐塩性のある増粘剤が好ましい。 <Thickener>
The composition of the invention may contain a thickening agent. When a thickening agent is used in combination with a salt (for example, the salt-type drug according to the present invention), the viscosity may decrease or air bubbles may be generated when the salt content is high. be. Therefore, in the present invention, salt-tolerant thickeners are preferable as the thickener from the viewpoint of preventing the composition from dripping, preventing air bubbles, or reducing resistance when applied to the skin.
本発明の組成物は、増粘剤を含有してもよい。増粘剤は、通常、塩（例えば、本発明にかかる塩型薬剤等）と併用すると、塩の含有量が多い場合には粘度が低下してしまうことや、気泡が発生してしまうことがある。したがって、本発明において、例えば組成物の垂れ防止、気泡防止、又は皮膚への適用の際の抵抗低減の観点からは、増粘剤として、耐塩性のある増粘剤が好ましい。 <Thickener>
The composition of the invention may contain a thickening agent. When a thickening agent is used in combination with a salt (for example, the salt-type drug according to the present invention), the viscosity may decrease or air bubbles may be generated when the salt content is high. be. Therefore, in the present invention, salt-tolerant thickeners are preferable as the thickener from the viewpoint of preventing the composition from dripping, preventing air bubbles, or reducing resistance when applied to the skin.
より具体的には、本発明の組成物は、増粘剤を含有し、かつ上述した塩型薬剤を含有する場合の組成物の粘度と、上述した塩型薬剤を含有しない場合の組成物の粘度との比（塩型薬剤を含有する場合の組成物の粘度／塩型薬剤を含有しない場合の組成物の粘度）が、５０％以上であることが好ましい。また、この比（塩型薬剤を含有する場合の組成物の粘度／塩型薬剤を含有しない場合の組成物の粘度）は、５０％以上、５５％以上、６０％以上、６５％以上、７０％以上、７５％以上、８０％以上、８５％以上、９０％以上、９５％以上、又は１００％であってよい。なお、本発明において、この比が５０％以上の増粘剤を「耐塩性のある増粘剤」として取り扱い、また「耐塩性増粘剤」とも称する。
More specifically, the composition of the present invention contains a thickener and the viscosity of the composition when it contains the above-mentioned salt-type drug, and the viscosity of the composition when it does not contain the above-mentioned salt-type drug. The viscosity ratio (viscosity of the composition containing the salt-type drug/viscosity of the composition not containing the salt-type drug) is preferably 50% or more. In addition, this ratio (viscosity of the composition containing the salt-type drug/viscosity of the composition not containing the salt-type drug) is 50% or more, 55% or more, 60% or more, 65% or more, 70% or more. % or more, 75% or more, 80% or more, 85% or more, 90% or more, 95% or more, or 100%. In the present invention, a thickener having a ratio of 50% or more is treated as a "salt-tolerant thickener" and is also referred to as a "salt-tolerant thickener".
このような耐塩性増粘剤の具体例としては、（ジメチルアクリルアミド／アクリロイルジメチルタウリンＮａ）クロスポリマー、サクシノグリカン、キサンタンガム、セルロース、アクリルアミド系共重合体、アクロイルジメチルタウリンナトリウム／アクリル酸ヒドロキシエチル共重合体、寒天、又は疎水性ポリエーテルウレタン等が挙げられるが、これらに限定されない。
Specific examples of such salt-tolerant thickeners include (dimethylacrylamide/sodium acryloyldimethyltaurate) crosspolymer, succinoglycan, xanthan gum, cellulose, acrylamide-based copolymer, sodium acryloyldimethyltaurate/hydroxyethyl acrylate. Examples include, but are not limited to, copolymers, agar, or hydrophobic polyether urethanes.
本発明の組成物において、増粘剤が含まれる場合のその含有量は、特に限定されず、組成物全量に対して、例えば０．０１質量％以上、０．０５質量％以上、１．０質量％以上、２．０質量％以上、又は３．０質量％以上であってよく、また５．０質量％以下であってよい。
In the composition of the present invention, the content of the thickener when it is included is not particularly limited, and is, for example, 0.01% by mass or more, 0.05% by mass or more, 1.0% or more, relative to the total amount of the composition. % by mass or more, 2.0% by mass or more, or 3.0% by mass or more, and may be 5.0% by mass or less.
（調製方法）
本発明の組成物は、イオン交換水等の水性溶媒中に、例えば上述した塩型薬剤、及び／又は増粘剤を添加して混合させることによって調製することができる。また、本発明の効果を損なわない限り、例えばキレート剤、油剤、界面活性剤、水溶性アルコール、高級アルコール、粉体、保湿剤、水溶性高分子皮膜剤、紫外線吸収剤、有機アミン、高分子エマルジョン、シリコーンエラストマー、ｐＨ調整剤、皮膚栄養剤、ビタミン類、酸化防止剤、酸化防止助剤、抽出液、防腐剤、消炎剤、賦活剤、血行促進剤、抗脂漏剤、色素、顔料、又は香料等のその他の成分を１種類以上添加してもよい。 (Preparation method)
The composition of the present invention can be prepared by adding, for example, the aforementioned salt-type drug and/or thickener to an aqueous solvent such as ion-exchanged water and mixing. In addition, as long as the effects of the present invention are not impaired, for example, chelating agents, oils, surfactants, water-soluble alcohols, higher alcohols, powders, moisturizing agents, water-soluble polymer coating agents, ultraviolet absorbers, organic amines, polymers Emulsions, silicone elastomers, pH adjusters, skin nutrients, vitamins, antioxidants, antioxidant aids, extracts, preservatives, anti-inflammatory agents, activators, blood circulation promoters, antiseborrheic agents, dyes, pigments, Alternatively, one or more other components such as perfume may be added.
本発明の組成物は、イオン交換水等の水性溶媒中に、例えば上述した塩型薬剤、及び／又は増粘剤を添加して混合させることによって調製することができる。また、本発明の効果を損なわない限り、例えばキレート剤、油剤、界面活性剤、水溶性アルコール、高級アルコール、粉体、保湿剤、水溶性高分子皮膜剤、紫外線吸収剤、有機アミン、高分子エマルジョン、シリコーンエラストマー、ｐＨ調整剤、皮膚栄養剤、ビタミン類、酸化防止剤、酸化防止助剤、抽出液、防腐剤、消炎剤、賦活剤、血行促進剤、抗脂漏剤、色素、顔料、又は香料等のその他の成分を１種類以上添加してもよい。 (Preparation method)
The composition of the present invention can be prepared by adding, for example, the aforementioned salt-type drug and/or thickener to an aqueous solvent such as ion-exchanged water and mixing. In addition, as long as the effects of the present invention are not impaired, for example, chelating agents, oils, surfactants, water-soluble alcohols, higher alcohols, powders, moisturizing agents, water-soluble polymer coating agents, ultraviolet absorbers, organic amines, polymers Emulsions, silicone elastomers, pH adjusters, skin nutrients, vitamins, antioxidants, antioxidant aids, extracts, preservatives, anti-inflammatory agents, activators, blood circulation promoters, antiseborrheic agents, dyes, pigments, Alternatively, one or more other components such as perfume may be added.
《美容シート》
本発明はまた、美容シートを提供する。ここで、美容シートとは、基材に目的の液状組成物を含侵させてなるものであり、皮膚に適用することができ、特に後述する美容処理装置と皮膚との間に配置されるものを指す。 《Beauty sheet》
The present invention also provides a cosmetic sheet. Here, the cosmetic sheet is made by impregnating a base material with the desired liquid composition, and can be applied to the skin, and is particularly placed between the skin and the cosmetic treatment apparatus described below. point to
本発明はまた、美容シートを提供する。ここで、美容シートとは、基材に目的の液状組成物を含侵させてなるものであり、皮膚に適用することができ、特に後述する美容処理装置と皮膚との間に配置されるものを指す。 《Beauty sheet》
The present invention also provides a cosmetic sheet. Here, the cosmetic sheet is made by impregnating a base material with the desired liquid composition, and can be applied to the skin, and is particularly placed between the skin and the cosmetic treatment apparatus described below. point to
本発明の美容シートは、上述した本発明の組成物が含侵されている。シートの基材へ含侵させる本発明の組成物の量は、シートの基材の材質によっても異なるが、例えば、本発明の組成物によりシートの基材全体が濡れる程度の量であってよく、具体的には、シートの基材の質量に対して１～３０倍量、５～２０倍量の本発明の組成物を含侵させてよい。
The cosmetic sheet of the present invention is impregnated with the composition of the present invention described above. The amount of the composition of the present invention impregnated into the base material of the sheet varies depending on the material of the base material of the sheet. More specifically, the composition of the present invention may be impregnated in an amount of 1 to 30 times, or 5 to 20 times the mass of the base material of the sheet.
美容シートの基材としては、例えば不織布又は紙等を用いてよい。不織布を構成する繊維の材質としては、コットン、レーヨン、パルプ、麻、アクリル、ナイロン、シルク、ポリアミド、ポリエステル、ポリウレタン、ポリプロピレン等、及びそれらの混合物が使用されるが、特にコットンは組成物の浸透含浸保持性が高く、肌触りが良いので好ましい。
As the base material of the cosmetic sheet, for example, non-woven fabric or paper may be used. As the material of the fibers that make up the non-woven fabric, cotton, rayon, pulp, hemp, acrylic, nylon, silk, polyamide, polyester, polyurethane, polypropylene, etc., and mixtures thereof are used. It is preferable because it has high impregnation retention and good texture.
美容シートの形状は、特に限定されず、皮膚の使用部位に合わせて適宜設定してよく、例えば、楕円形、円形、ハート形、半円形、半楕円形、正方形、長方形、台形等が挙げられるがこれらに限定されない。また、美容シートは、中心部や周辺部に位置合わせや使用性改善の目的で凸部や凹部を設けてもよく、また使用部位により、美容シートの厚さや組成を変化させてもよい。
The shape of the cosmetic sheet is not particularly limited, and may be appropriately set according to the site of use of the skin. are not limited to these. In addition, the cosmetic sheet may be provided with protrusions or recesses in the central part or the peripheral part for the purpose of alignment and usability improvement, and the thickness and composition of the cosmetic sheet may be changed depending on the use site.
シートの基材に本発明の組成物を含侵させる方法は、特に限定されず、例えば公知の、滴下法、噴霧法、加圧法、又はディッピング加工法が挙げられる。シートの基材は、そのままあるいは折りたたむ等して１枚又は複数枚を用い、本発明の組成物を含浸させることができる。
The method for impregnating the base material of the sheet with the composition of the present invention is not particularly limited, and examples thereof include a known dropping method, spraying method, pressurizing method, or dipping method. The base material of the sheet can be used as it is or as a folded sheet or a plurality of sheets, and can be impregnated with the composition of the present invention.
《美容処理装置》
本発明はまた、美容処理装置を提供する。 《Beauty treatment device》
The present invention also provides a cosmetic treatment device.
本発明はまた、美容処理装置を提供する。 《Beauty treatment device》
The present invention also provides a cosmetic treatment device.
本発明の美容処理装置は、上述した本発明の組成物、又は上述した本発明の美容シートを介して、皮膚に電圧印加美容処理を行う美容処理装置であって、
電圧印加部及び制御部を含み、
電圧印加部が、同一の平面上に少なくとも２つの電極を有し、かつ
制御部が、電圧印加部の少なくとも２つの電極間の交流電圧又は直流パルス電圧の周波数を５００ｋＨｚ～５０ＭＨｚに制御する、
装置
である。 The cosmetic treatment apparatus of the present invention is a cosmetic treatment apparatus that performs voltage application cosmetic treatment on the skin via the composition of the present invention described above or the cosmetic sheet of the present invention described above,
including a voltage application unit and a control unit,
The voltage application unit has at least two electrodes on the same plane, and the control unit controls the frequency of the AC voltage or DC pulse voltage between the at least two electrodes of the voltage application unit to 500 kHz to 50 MHz.
It is a device.
電圧印加部及び制御部を含み、
電圧印加部が、同一の平面上に少なくとも２つの電極を有し、かつ
制御部が、電圧印加部の少なくとも２つの電極間の交流電圧又は直流パルス電圧の周波数を５００ｋＨｚ～５０ＭＨｚに制御する、
装置
である。 The cosmetic treatment apparatus of the present invention is a cosmetic treatment apparatus that performs voltage application cosmetic treatment on the skin via the composition of the present invention described above or the cosmetic sheet of the present invention described above,
including a voltage application unit and a control unit,
The voltage application unit has at least two electrodes on the same plane, and the control unit controls the frequency of the AC voltage or DC pulse voltage between the at least two electrodes of the voltage application unit to 500 kHz to 50 MHz.
It is a device.
ここで、本発明の組成物又は本発明の美容シートを介することとは、美容処理装置を皮膚に処理を行う際に、美容処理装置と皮膚との間に本発明の組成物又は本発明の美容シートをその両者に接触させる態様である。
Here, passing the composition of the present invention or the cosmetic sheet of the present invention means that the composition of the present invention or the cosmetic sheet of the present invention is placed between the cosmetic treatment device and the skin when the skin is treated with the cosmetic treatment device. This is a mode in which the cosmetic sheet is brought into contact with both.
また、本発明の組成物を介する場合には、本発明の組成物が美容処理装置に塗布されていてもよく、皮膚に塗布されてもいてもよく、又は美容処理装置と皮膚との両方に塗布されていてもよい。また、本発明の美容シートを介する場合には、シートの大きさにもよるが、操作便宜の観点から、本発明の美容シートを先に皮膚に覆ってから美容処理装置を適用することが好ましい。
In the case of using the composition of the present invention, the composition of the present invention may be applied to the cosmetic treatment device, may be applied to the skin, or may be applied to both the cosmetic treatment device and the skin. It may be coated. When the cosmetic sheet of the present invention is used, it is preferable to cover the skin with the cosmetic sheet of the present invention first, and then apply the cosmetic treatment device, depending on the size of the sheet, from the viewpoint of convenience of operation. .
美容処理装置において、電圧印加部は、同一の平面上に少なくとも２つの電極を有し、この２つの電極によって皮膚に高周波の電圧印加することができる。本発明において、高周波の電圧は、例えば周波数５００ｋＨｚ～５０ＭＨｚの電圧であってよい。
In the beauty treatment device, the voltage application section has at least two electrodes on the same plane, and the two electrodes can apply a high-frequency voltage to the skin. In the present invention, the high-frequency voltage may be, for example, voltage with a frequency of 500 kHz to 50 MHz.
美容処理装置において、制御部は、電圧印加部の少なくとも２つの電極間の交流電圧又は直流パルス電圧の周波数を、例えば５００ｋＨｚ～５０ＭＨｚに制御することができる。
In the beauty treatment device, the control section can control the frequency of the AC voltage or DC pulse voltage between at least two electrodes of the voltage application section to, for example, 500 kHz to 50 MHz.
また、美容処理装置には、例えば２つの電極の間の抵抗値を測定する測定部を更に含んでよい。この測定部から得られた抵抗値に応じて、制御部は交流電圧又は直流パルス電圧の周波数を、例えば５００ｋＨｚ～５０ＭＨｚに制御することができる。
In addition, the beauty treatment device may further include, for example, a measurement unit that measures the resistance value between the two electrodes. The control section can control the frequency of the AC voltage or the DC pulse voltage to, for example, 500 kHz to 50 MHz according to the resistance value obtained from the measurement section.
なお、本発明において、市販の皮膚に電圧印加美容処理を行う美容処理装置、例えばＲＦ美顔器等を用いてよい。
In addition, in the present invention, a commercially available beauty treatment device that performs voltage application beauty treatment on the skin, such as an RF facial equipment, may be used.
本発明の美容処理装置によれば、本発明の組成物又は本発明の組成物が含侵されている美容シートを介することによって、皮膚への温熱効果をより効率的に行うことができる。
According to the cosmetic treatment apparatus of the present invention, the thermal effect on the skin can be more efficiently performed through the composition of the present invention or the cosmetic sheet impregnated with the composition of the present invention.
《美容方法》
本発明はまた、美容方法を提供する。 《Beauty method》
The present invention also provides a cosmetic method.
本発明はまた、美容方法を提供する。 《Beauty method》
The present invention also provides a cosmetic method.
本発明の美容方法は、上述した本発明の組成物、又は上述した本発明の美容シートを介して、電圧印加美容処理装置を用いる方法である。ここで、電圧印加美容処理装置としては、上述した本発明の美容処理装置を用いてもよく、市販の皮膚に電圧印加美容処理を行う美容処理装置、例えばＲＦ美顔器等を用いてよい。
The cosmetic method of the present invention is a method using a voltage-applied cosmetic treatment apparatus via the composition of the present invention or the cosmetic sheet of the present invention. Here, as the voltage application cosmetic treatment apparatus, the above-described beauty treatment apparatus of the present invention may be used, or a commercially available beauty treatment apparatus for applying voltage application cosmetic treatment to the skin, for example, an RF facial device may be used.
本発明の美容方法によれば、本発明の組成物又は本発明の組成物が含侵されている美容シートを介することによって、皮膚への温熱効果をより効率的に行うことができる。
According to the cosmetic method of the present invention, the thermal effect on the skin can be performed more efficiently through the composition of the present invention or the cosmetic sheet impregnated with the composition of the present invention.
以下に実施例を挙げて、本発明について更に詳しく説明を行うが、本発明はこれらに限定されるものではない。なお、以下、特に断りのない限り、含有量又は配合量は、質量％で示す。
The present invention will be described in more detail below with reference to examples, but the present invention is not limited to these. In addition, hereinafter, unless otherwise specified, the content or compounding amount is indicated by mass %.
《実施例及び比較例》
以下に示す表１～５の処方に基づき、各実施例及び比較例の組成物を調製した。 <<Examples and Comparative Examples>>
Compositions of Examples and Comparative Examples were prepared based on the formulations shown in Tables 1 to 5 below.
以下に示す表１～５の処方に基づき、各実施例及び比較例の組成物を調製した。 <<Examples and Comparative Examples>>
Compositions of Examples and Comparative Examples were prepared based on the formulations shown in Tables 1 to 5 below.
（導電率）
各実施例及び比較例の組成物の２５℃における導電率を測定し、それらの結果を表１～５に示す。なお、導電率の測定は株式会社堀場製作所社製のポータブル型電気伝導率計ＥＳ－７１を用いた。 (conductivity)
The conductivity at 25° C. of the composition of each example and comparative example was measured, and the results are shown in Tables 1-5. A portable electrical conductivity meter ES-71 manufactured by HORIBA, Ltd. was used for the measurement of electrical conductivity.
各実施例及び比較例の組成物の２５℃における導電率を測定し、それらの結果を表１～５に示す。なお、導電率の測定は株式会社堀場製作所社製のポータブル型電気伝導率計ＥＳ－７１を用いた。 (conductivity)
The conductivity at 25° C. of the composition of each example and comparative example was measured, and the results are shown in Tables 1-5. A portable electrical conductivity meter ES-71 manufactured by HORIBA, Ltd. was used for the measurement of electrical conductivity.
（粘度及び粘度の比）
一部の実施例及び比較例の組成物に対して粘度を測定し、それらの結果を表１～５に示す。そして、それらの組成物について、塩型薬剤を含有する場合の組成物の粘度と、塩型薬剤を含有しない場合の組成物の粘度との比（塩型薬剤を含有する場合の組成物の粘度／塩型薬剤を含有しない場合の組成物の粘度）を求め、表１～５に示す。 (Ratio of viscosity and viscosity)
Viscosity was measured for some of the Example and Comparative compositions and the results are shown in Tables 1-5. Then, for those compositions, the ratio of the viscosity of the composition containing the salt-type drug to the viscosity of the composition not containing the salt-type drug (viscosity of the composition containing the salt-type drug /viscosity of the composition without salt-type drug) was determined and shown in Tables 1-5.
一部の実施例及び比較例の組成物に対して粘度を測定し、それらの結果を表１～５に示す。そして、それらの組成物について、塩型薬剤を含有する場合の組成物の粘度と、塩型薬剤を含有しない場合の組成物の粘度との比（塩型薬剤を含有する場合の組成物の粘度／塩型薬剤を含有しない場合の組成物の粘度）を求め、表１～５に示す。 (Ratio of viscosity and viscosity)
Viscosity was measured for some of the Example and Comparative compositions and the results are shown in Tables 1-5. Then, for those compositions, the ratio of the viscosity of the composition containing the salt-type drug to the viscosity of the composition not containing the salt-type drug (viscosity of the composition containing the salt-type drug /viscosity of the composition without salt-type drug) was determined and shown in Tables 1-5.
なお、粘度の測定は、東機産業株式会社製のＴＶＢ－１０Ｈ型度計を用いた。測定条件は、２５℃において、ロータＮｏＴＨ７、回転速度１０ｒｐｍ、回転時間６０秒後の粘度値を測定した。
The viscosity was measured using a TVB-10H degree meter manufactured by Toki Sangyo Co., Ltd. The measurement conditions were 25° C., a rotor NoTH7, a rotation speed of 10 rpm, and a viscosity value after 60 seconds of rotation.
（温熱効果の効率評価）
実施例１及び３、並びに比較例１及び２の組成物に対して、以下のように温熱効果を測定し、評価した。 (Efficiency evaluation of thermal effect)
The thermal effects of the compositions of Examples 1 and 3 and Comparative Examples 1 and 2 were measured and evaluated as follows.
実施例１及び３、並びに比較例１及び２の組成物に対して、以下のように温熱効果を測定し、評価した。 (Efficiency evaluation of thermal effect)
The thermal effects of the compositions of Examples 1 and 3 and Comparative Examples 1 and 2 were measured and evaluated as follows.
より具体的には、株式会社ビューラックス社製の頬部肌模型上に３０ｍｍ×３０ｍｍの人工皮革片（出光テクノファイン社製サプラーレ）を置き、各組成物サンプル２０ｍｇ／ｃｍ２を人工皮革片上に塗布した。次に、組成物サンプルが塗布された人工皮革片に周波数１ＭＨｚの電圧を出力する電極を適用し、温度測定をした。なお、無塗布のサンプルをブランクとして用いた。また、温度測定は、熱電対を頬部模型と人工皮革片の間に貼り付けて日置電機株式会社製のメモリハイロガーＬＲ８４３１で記録し、電極適用前１０秒から測定を開始して、表示温度が５０℃を超えるか又は２分（１２０秒）経過するまで測定を行った。
More specifically, a 30 mm × 30 mm piece of artificial leather (Suprale, manufactured by Idemitsu Techno Fine Co., Ltd.) is placed on a cheek skin model manufactured by Beaulux Co., Ltd., and 20 mg/cm 2 of each composition sample is placed on the artificial leather piece. applied. Next, an electrode that outputs a voltage with a frequency of 1 MHz was applied to the piece of artificial leather coated with the composition sample, and the temperature was measured. A non-coated sample was used as a blank. In addition, the temperature measurement was performed by attaching a thermocouple between the cheek model and the piece of artificial leather and recording it with a memory high logger LR8431 manufactured by Hioki Electric Co., Ltd., starting measurement 10 seconds before applying the electrode, and displaying the temperature. Measurements were taken until the temperature exceeded 50° C. or 2 minutes (120 seconds) elapsed.
そして、評価は、各組成物に対して、測定時間ごとの初期温度からの温度変化を求めて比較した。それらの結果を図１に示す。
Then, for the evaluation, the temperature change from the initial temperature for each measurement time was obtained and compared for each composition. Those results are shown in FIG.
表１～５から明らかであるように、実施例の組成物はいずれも２５℃において、導電率が０．５Ｓ／ｍ以上であることが分かった。
As is clear from Tables 1 to 5, it was found that all the compositions of Examples had a conductivity of 0.5 S/m or more at 25°C.
図１から明らかであるように、導電率と温熱効果との相関があるが分かった。すなわち、導電率の高い順につれ、実施例３（１．１３７Ｓ／ｍ）、実施例１（０．５６８Ｓ／ｍ）、比較例２（０．３７１Ｓ／ｍ）及び比較例１（０．２２２Ｓ／ｍ）の温熱効果による温度の上昇（温度変化）もこの順で大きくなっていくことが分かった。
As is clear from Figure 1, it was found that there is a correlation between conductivity and thermal effect. That is, in descending order of conductivity, Example 3 (1.137 S / m), Example 1 (0.568 S / m), Comparative Example 2 (0.371 S / m) and Comparative Example 1 (0.222 S / It was found that the temperature rise (temperature change) due to the thermal effect of m) also increases in this order.
また、実施例１及び３の温熱効果は、いずれも比較例１及び２よりも効率的に得ることが分かった。
In addition, it was found that the thermal effects of Examples 1 and 3 are obtained more efficiently than Comparative Examples 1 and 2.
Claims (8)
- ２５℃において、導電率が０．５Ｓ／ｍ以上である、電圧印加美容処理用組成物。 A voltage-applied cosmetic treatment composition having a conductivity of 0.5 S/m or more at 25°C.
- 塩型薬剤を含有している、請求項１に記載の組成物。 The composition according to claim 1, which contains a salt-form drug.
- 前記塩型薬剤が、塩型美白剤を含む、請求項２に記載の組成物。 The composition according to claim 2, wherein the salt-type agent comprises a salt-type whitening agent.
- 前記塩型薬剤の含有量が、０．２質量％以上である、請求項２又は３に記載の組成物。 The composition according to claim 2 or 3, wherein the content of the salt-type drug is 0.2% by mass or more.
- 増粘剤を含有し、かつ
前記塩型薬剤を含有する場合の前記組成物の粘度と、前記塩型薬剤を含有しない場合の前記組成物の粘度との比（前記塩型薬剤を含有する場合の前記組成物の粘度／前記塩型薬剤を含有しない場合の前記組成物の粘度）が、５０％以上である、
請求項２～４のいずれか一項に記載の組成物。 The ratio of the viscosity of the composition containing a thickener and containing the salt-form drug to the viscosity of the composition not containing the salt-form drug (when the salt-form drug is contained The viscosity of the composition of / the viscosity of the composition when not containing the salt-type drug) is 50% or more,
A composition according to any one of claims 2-4. - 請求項１～５のいずれか一項に記載の組成物が含浸されている、美容シート。 A cosmetic sheet impregnated with the composition according to any one of claims 1 to 5.
- 請求項１～５のいずれか一項に記載の組成物、又は請求項６に記載の美容シートを介して、皮膚に電圧印加美容処理を行う美容処理装置であって、
電圧印加部及び制御部を含み、
前記電圧印加部が、同一の平面上に少なくとも２つの電極を有し、かつ
前記制御部が、前記電圧印加部の少なくとも２つの前記電極間の交流電圧又は直流パルス電圧の周波数を５００ｋＨｚ～５０ＭＨｚに制御する、
装置。 A cosmetic treatment apparatus for performing voltage application cosmetic treatment on the skin via the composition according to any one of claims 1 to 5 or the cosmetic sheet according to claim 6,
including a voltage application unit and a control unit,
The voltage application unit has at least two electrodes on the same plane, and the control unit sets the frequency of the AC voltage or DC pulse voltage between the at least two electrodes of the voltage application unit to 500 kHz to 50 MHz. Control,
Device. - 請求項１～５のいずれか一項に記載の組成物、又は請求項６に記載の美容シートを介して、電圧印加美容処理装置を用いる、美容方法。 A cosmetic method using a voltage-applied beauty treatment device via the composition according to any one of claims 1 to 5 or the cosmetic sheet according to claim 6.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023505552A JPWO2022191146A1 (en) | 2021-03-11 | 2022-03-07 | |
| CN202280014610.XA CN116867473A (en) | 2021-03-11 | 2022-03-07 | Composition for cosmetic treatment by applying voltage, cosmetic sheet, cosmetic treatment device, and cosmetic method |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021039648 | 2021-03-11 | ||
| JP2021-039648 | 2021-03-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2022191146A1 true WO2022191146A1 (en) | 2022-09-15 |
Family
ID=83226671
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2022/009804 WO2022191146A1 (en) | 2021-03-11 | 2022-03-07 | Composition for use in voltage application cosmetic treatment, cosmetic sheet, cosmetic treatment device, and cosmetic method |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPWO2022191146A1 (en) |
| CN (1) | CN116867473A (en) |
| WO (1) | WO2022191146A1 (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002265348A (en) * | 2001-03-07 | 2002-09-18 | Ito Hajime | Composition for external use |
| JP2007131547A (en) * | 2005-11-08 | 2007-05-31 | Shiseido Co Ltd | Method of cosmetic treatment by iontophoresis |
| JP2007130076A (en) * | 2005-11-08 | 2007-05-31 | Shiseido Co Ltd | Promotion of transdermal delivery of water-soluble medicament |
| JP2007319474A (en) * | 2006-06-01 | 2007-12-13 | Tokyo Health:Kk | Cosmetic liquid agent penetrating apparatus and method |
| JP2009537494A (en) * | 2006-05-15 | 2009-10-29 | エルブイエムエイチ レシェルシェ | Aqueous cosmetic composition especially for use as a moisturizing lotion |
| JP2014074003A (en) * | 2012-10-04 | 2014-04-24 | Doctor's Kit Co Ltd | Production method of external agent for high-conductive cosmetic equipment |
| JP2015142698A (en) * | 2013-12-25 | 2015-08-06 | 株式会社 Ｍｔｇ | Beauty method |
-
2022
- 2022-03-07 JP JP2023505552A patent/JPWO2022191146A1/ja active Pending
- 2022-03-07 WO PCT/JP2022/009804 patent/WO2022191146A1/en active Application Filing
- 2022-03-07 CN CN202280014610.XA patent/CN116867473A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002265348A (en) * | 2001-03-07 | 2002-09-18 | Ito Hajime | Composition for external use |
| JP2007131547A (en) * | 2005-11-08 | 2007-05-31 | Shiseido Co Ltd | Method of cosmetic treatment by iontophoresis |
| JP2007130076A (en) * | 2005-11-08 | 2007-05-31 | Shiseido Co Ltd | Promotion of transdermal delivery of water-soluble medicament |
| JP2009537494A (en) * | 2006-05-15 | 2009-10-29 | エルブイエムエイチ レシェルシェ | Aqueous cosmetic composition especially for use as a moisturizing lotion |
| JP2007319474A (en) * | 2006-06-01 | 2007-12-13 | Tokyo Health:Kk | Cosmetic liquid agent penetrating apparatus and method |
| JP2014074003A (en) * | 2012-10-04 | 2014-04-24 | Doctor's Kit Co Ltd | Production method of external agent for high-conductive cosmetic equipment |
| JP2015142698A (en) * | 2013-12-25 | 2015-08-06 | 株式会社 Ｍｔｇ | Beauty method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN116867473A (en) | 2023-10-10 |
| JPWO2022191146A1 (en) | 2022-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106687149B (en) | Hydrogel composition | |
| CN105456057B (en) | Water-locking and moisturizing composition with mousse texture | |
| JP5822427B2 (en) | Cosmetic composition comprising an ascorbic acid or salicylic acid compound | |
| JP6760732B2 (en) | Skin shape change inhibitor | |
| WO2018099931A1 (en) | Anti-perspirant composition comprising chitosan | |
| JP5743406B2 (en) | Cosmetic or dermatological composition containing a retinoid, an adenosine-based non-phosphated compound and a semi-crystalline polymer | |
| CN115137667B (en) | Cosmetic composition with penetration promoting effect and application thereof | |
| WO2022191146A1 (en) | Composition for use in voltage application cosmetic treatment, cosmetic sheet, cosmetic treatment device, and cosmetic method | |
| JP7543611B2 (en) | Skin care sheets | |
| JP2017043588A (en) | Kit for skin external preparation | |
| JP7148257B2 (en) | body cosmetics | |
| JP2005289995A (en) | Oil/water type cosmetic composition manufactured using polyglyceryl-3-methylglucose distearate | |
| JP2021504358A (en) | A mascara composition containing a polymer having a cyclic amide, a cyclic amine, and acrylamide. | |
| KR100535261B1 (en) | A cosmetic having hydrogel matrix adsheive sheet type | |
| JP2019077675A (en) | Gel-like external preparation for skin and skin cosmetic | |
| JP6985752B2 (en) | Kit for external skin preparation | |
| CN105992582B (en) | External preparation for skin | |
| KR20130060618A (en) | Mask composition with high coverage to skin | |
| US10912724B2 (en) | Compositions for removing nail polish | |
| JP2018062484A (en) | Sheet-like cosmetic | |
| JP2000290153A (en) | Skin preparation for external use | |
| JP2003095880A (en) | Hair cosmetic | |
| JP2000178125A (en) | Cosmetics for skin | |
| WO2024116893A1 (en) | Composition | |
| JP2009221183A (en) | Hair cosmetic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22767101 Country of ref document: EP Kind code of ref document: A1 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2023505552 Country of ref document: JP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 202280014610.X Country of ref document: CN |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 22767101 Country of ref document: EP Kind code of ref document: A1 |